Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02117752 · ClinicalTrials.gov registry record · Phase 1
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
A Phase 1 study, sponsored by Almirall, S.A..
- Completed
- Registry status
- Phase 1
- Development phase
- 237
- Enrollment target
NCT02117752 is a Phase 1 study that has completed, run by Almirall, S.A.. The registered enrollment target is 237 participants.
The verdict
NCT02117752, a Phase 1 study, has completed, sponsored by Almirall, S.A..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 237 participants
- Enrollment target
Study Summary
This study will determine the cumulative irritation potential and sensitization potential of dapsone gel and vehicle after repeat applications on the skin of healthy volunteers.
Interventions
- DRUG Normal saline
- DRUG dapsone gel
- DRUG dapsone gel vehicle
- DRUG sodium lauryl sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02117752
The ClinicalTrials.gov registry entry for NCT02117752 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Almirall, S.A., which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Normal saline is the first listed.
NCT02117752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02117752 about?
NCT02117752 is a clinical study titled "Dermal Tolerability of Dapsone Gel in Healthy Volunteers". This study will determine the cumulative irritation potential and sensitization potential of dapsone gel and vehicle after repeat applications on the skin of healthy volunteers.
What is the current status of trial NCT02117752?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 237 participants. The study started on 2014-04. Estimated completion is 2014-07.
What interventions are being tested in trial NCT02117752?
The interventions under investigation include: Normal saline (DRUG), dapsone gel (DRUG), dapsone gel vehicle (DRUG), sodium lauryl sulfate (DRUG).
Who is sponsoring clinical trial NCT02117752?
This trial is sponsored by Almirall, S.A., which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.